346 related articles for article (PubMed ID: 3010072)
1. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 May; 35(20):334-9. PubMed ID: 3010072
[TBL] [Abstract][Full Text] [Related]
2. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. Centers for Disease Control, U.S. Department of Health and Human Services.
Ann Intern Med; 1986 Aug; 105(2):234-7. PubMed ID: 3014942
[TBL] [Abstract][Full Text] [Related]
3. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
[TBL] [Abstract][Full Text] [Related]
4. The Walter Reed staging classification for HTLV-III/LAV infection.
Redfield RR; Wright DC; Tramont EC
N Engl J Med; 1986 Jan; 314(2):131-2. PubMed ID: 2934633
[TBL] [Abstract][Full Text] [Related]
5. A classification of HTLV-III infection based on 75 cases seen in a suburban community.
Kaplan MH; Pahwa SG; Popovic M; Sarngadharan MG; Gallo RC
Cancer Res; 1985 Sep; 45(9 Suppl):4655s-4658s. PubMed ID: 2990703
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
Yarchoan R; Redfield RR; Broder S
J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
[TBL] [Abstract][Full Text] [Related]
7. Immunization of children infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus. Recommendations of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
Ann Intern Med; 1987 Jan; 106(1):75-8. PubMed ID: 3024547
[TBL] [Abstract][Full Text] [Related]
8. Tuberculosis--United States, 1985--and the possible impact of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 Feb; 35(5):74-6. PubMed ID: 3080659
[TBL] [Abstract][Full Text] [Related]
9. Acquired immune deficiency syndrome (AIDS)--recommendations of IMAP.
International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
IPPF Med Bull; 1986 Jun; 20(3):3-4. PubMed ID: 12268332
[TBL] [Abstract][Full Text] [Related]
10. AIDS: the search for clues.
WHO Chron; 1985; 39(6):207-11. PubMed ID: 3012884
[TBL] [Abstract][Full Text] [Related]
11. Leads from the MMWR. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.
JAMA; 1986 Jul; 256(1):20-1, 24-5. PubMed ID: 3012133
[No Abstract] [Full Text] [Related]
12. In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV).
Nicholson JK; Cross GD; Callaway CS; McDougal JS
J Immunol; 1986 Jul; 137(1):323-9. PubMed ID: 3011909
[TBL] [Abstract][Full Text] [Related]
13. Revision of the case definition of acquired immunodeficiency syndrome for national reporting--United States. Centers for Disease Control, Department of Health and Human Services.
Ann Intern Med; 1985 Sep; 103(3):402-3. PubMed ID: 2992336
[TBL] [Abstract][Full Text] [Related]
14. Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus. Centers for Disease Control, Department of Health and Human Services.
Ann Intern Med; 1986 Oct; 105(4):558-9. PubMed ID: 3019202
[TBL] [Abstract][Full Text] [Related]
15. Revision of the case definition of acquired immunodeficiency syndrome for national reporting--United States.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1985 Jun; 34(25):373-5. PubMed ID: 2989677
[TBL] [Abstract][Full Text] [Related]
16. Transfusion-associated acquired immunodeficiency syndrome. Evidence for persistent infection in blood donors.
Feorino PM; Jaffe HW; Palmer E; Peterman TA; Francis DP; Kalyanaraman VS; Weinstein RA; Stoneburner RL; Alexander WJ; Raevsky C
N Engl J Med; 1985 May; 312(20):1293-6. PubMed ID: 2985992
[TBL] [Abstract][Full Text] [Related]
17. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
[TBL] [Abstract][Full Text] [Related]
18. Occupational risk of the acquired immunodeficiency syndrome among health care workers.
McCray E
N Engl J Med; 1986 Apr; 314(17):1127-32. PubMed ID: 3485769
[TBL] [Abstract][Full Text] [Related]
19. Neurology of AIDS virus infection: a clinical classification.
Booss J; Harris SA
Yale J Biol Med; 1987; 60(6):537-43. PubMed ID: 2829450
[TBL] [Abstract][Full Text] [Related]
20. Human T-cell lymphotropic virus type III associated disorders. The spectrum in the heterosexual population.
Gill PS; Levine AM; Meyer PR; Aguilar SL; Rarick M; Parker JW; Rasheed S
Arch Intern Med; 1986 Aug; 146(8):1501-4. PubMed ID: 3015064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]